Filing Details
- Accession Number:
- 0001209191-21-056609
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-17 16:04:52
- Reporting Period:
- 2021-09-15
- Accepted Time:
- 2021-09-17 16:04:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 924717 | Surmodics Inc | SRDX | Surgical & Medical Instruments & Apparatus (3841) | 411356149 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1508798 | R Gary Maharaj | 9924 West 74Th Street Eden Prairie MN 55344 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-09-15 | 1,030 | $56.68 | 163,781 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-15 | 4,970 | $57.34 | 158,811 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2021.
- Reflects the weighted average price of 1,030 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on September 15, 2021 with sale prices ranging from $56.13 to $57.12 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Includes 98 shares acquired through the Employee Stock Purchase Plan for the phase ending August 31, 2021.
- Reflects the weighted average price of 4,970 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on September 15, 2021 with sale prices ranging from $57.16 to $57.57 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
